Consortium boosts Biomet bid

A private equity consortium has become the latest bidder to bow to pressure from investors and sweeten its offer for artificial joint maker Biomet by nearly 5%.

Biomet recommended shareholders support the $11.4bn (€8.5bn) bid from private equity groups Blackstone Group, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts and TPG.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump